Project Grant R21DA066213
Award Date 7/1/26
Completion Date 6/30/28
Dollars Obligated $428K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $230,421 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded June 1, 2026, with completion scheduled for May 31, 2027. This research project investigates the effect of genetic background on functional brain networks activated in response to cocaine using whole-brain imaging techniques. The research leverages tissue clearing...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $1.74M Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded September 30, 2025, with completion targeted for May 31, 2030. The grant funds research investigating cell type and circuit-specific epigenetic mechanisms underlying cocaine addiction. Using a novel methodology combining inducible barcoded rabies virus with...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA), under its Drug Use and Addiction Research Programs (CFDA 93.279), awarded $877,500 to the University of California, San Diego for a two-year project (July 15, 2025 through June 30, 2027) investigating neurobiological mechanisms underlying cocaine use disorder (CUD) susceptibility. The project employs a novel polygenic prediction methodology called RATTACA to identify pre-existing cellular differences in gabaergic and...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the Lieber Institute for Brain Development a Project Grant of $1.855 million under the Drug Use and Addiction Research Programs (CFDA 93.279), effective March 1, 2026 through February 28, 2029. The grant funds development of three-dimensional cellular-resolution spatio-molecular maps of the human nucleus accumbens (NAC), a critical brain region implicated in reward signaling and substance use disorders. The primary...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Boston Children's Hospital a $800,131 Project Grant effective May 1, 2026, through February 28, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). This award supports basic neuroscience research investigating the functions and mechanisms of a molecularly defined prefrontal cortex (PFC) neuron subtype in drug addiction. The research focuses on characterizing POU3F1-expressing layer 5 neurons...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded UC San Diego a $197,500 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, through August 31, 2027. The award supports development and validation of an in vivo Massively Parallel Reporter Assay (MPRA) methodology to characterize the functional role of cis-regulatory elements and genetic variants associated with substance use disorders. Specifically, the...
- Federal Grant Award Summary Wake Forest University Health Sciences received a $1.4M Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective September 1, 2025, through May 31, 2030. The award funds translational research to identify nociceptin/orphanin FQ peptide (NOP) receptors as pharmacological targets for treating cocaine use disorder (CUD). The research leverages nonhuman primate models combined with...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of North Carolina at Chapel Hill $1,407,350 under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and test a novel therapeutic approach targeting HIV's persistent central nervous system (CNS) reservoir. The grant, awarded August 15, 2025 with completion by May 31, 2030, funds research into transcriptional inactivation of the HIV reservoir using TAT-targeting lipid...
- Federal Grant Award Summary The University of South Carolina received a $192,149 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded February 1, 2026, with completion targeted for January 31, 2028. This award funds research investigating the noradrenergic mechanisms underlying stress-induced opioid reinstatement, with a focus on understanding how stress-related neural activity drives opioid-seeking behaviors....
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded SUNY Downstate Health Sciences University a $6.94 million Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a longitudinal investigation of neighborhood conditions, neural circuits, and substance use behaviors across the early life course. The award, effective September 30, 2025, through June 30, 2029, addresses the multifactorial etiology of substance use disorders...